HIT-GBM: Multicenter study for childhood malignant gIioma;HIT-GBM: MULTIZENTRISCHE STUDIE ZUR BEHANDLUNG VON KINDERN MIT MALIGNEN GLIOMEN

Klinische Padiatrie

Volumn 208, Issue 4, 1996, Pages 193-196

  Wolff, Johannes E A ^a,c   Boos, Joachim ^a   Kühl, Joachim ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Etoposide; Glioblastoma; Trofosfamide

Indexed keywords

ETOPOSIDE; TROFOSFAMIDE;

ASTROCYTOMA; BRAIN TUMOR; CHILDHOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; SHORT SURVEY;

EID: 0030018495     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1046473     Document Type: Short Survey

References (37)

1. Albright, A. L., et al.: Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the children's cancer group. Neurosurgery 33 (1993) 1026-1030
2. Allen, J. C., et al.: Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Sem. Oncol. 13 (1986) 110-112
3. Boos, J., et al.: Trofosfamides metabolism in different species - ifosfamide is the predominant metabolite. Cancer Chemother, Pharmacol, 33 (1993) 71-76
4. Chastagner, P., Sommelet, D.: Role of chemotherapy in the treatment of brain tumors: Place de la chimiotherapie dans le traitement des tumeurs cerebrales. Pediatrie 46 (1991) 47-58
5. Culver, K. W., et al.: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256 (1992) 1550-1552
6. Eade, O. E., H. Ulrich: Metastazing glioma in young subjects. J. Pathol. 103 (1970) 245-256
7. Elrich, S. S., R. L. Davis: Sinal arachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42 (1978) 2854-2864
8. Epstein, F., J. Wisoff: Intrinsic brain stem tumors in childhood: Surgical indications. J. Neurooncol. 6 (1989) 309-314
9. Fadul, C., et al.: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38 (1988) 1374-1379
10. Falkson, G., H. C. Falkson: Trofosfamide in the treatment of patients with cancer - a pilot trial. S. African Med. J. 53 (1978) 886-888
11. Finlay, J., et al.: Randomized phase III trial in childhood high grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regiment. J. Clin.-Oncol. 13 (1995) 112-123
12. Finn, G. P., et al.: High-Dose etoposide in the treatment of relapsed primary brain tumors. Cancer Treat. Rep. 69 (1985) 603-605
13. Frankel, S. A., W. J. German: Glioblastoma multiforme Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J. Neurosurg. 15 (1958) 489-503
14. Gyepes, M. T., G. J. D'Angio: Extracranial metastases from central nervous tumors in children and adolescents. Radiology 87 (1966) 55-63
15. Jaeckle, K. A., et al.: Phase II trial of Serracia marcescens extract in recurrent malignant astrocytoma. J. Clin. Oncol. 8 (1990) 1408-1418
16. Jordan, J. P., et al.: Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. N. Neurooncol. 14 (1993) 19-35
17. Kleihues, P. C., et al.: Histological typing of tumor of the central nervous system. In: B. W. Scheithauer (Hrsg.): WHO interantional histilogy classification of tumors (2nd edition). Springer 1993
18. Komatsu, K., et al.: Widespread extraneural metastases of glioblastoma multiforme. Report of a case and review of the cases in the literature. Brain Nerve 24 (1972) 339-351
19. Krümpelmann, S., et al.: Intensive and prolonged treatment with oral trofosfamide and etoposide on an outpatient basis. Med. Ped. Oncol. 25 (1995) 321
20. Kühl, J.: Chemotherapie bei Hirntumoren im Kindesalter - Literaturübersicht und Pilotprotokoll. Klin. Pädiat. 200 (1988) 214-218
21. Kühl, J., et al.: Ergebnisse der multizentrischen Chemotherapiepilotstudie HIT 1988/1989. In: Köhler, B., R. Keimer, 1992: Aktuelle Neuropädiatrie. Springer, pp 176-184
22. Levin, V. A., et al.: Modified procarbacine, CCNU and vincristine (PCV) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat. Rep. 64 (1980) 237-241
23. Malkin, M. G., et al.: Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group. J. Neuro-Oncol. 22 (1994) 55-65
24. Molloy, P., et al.: Brain stem neoplasms. Med. Ped. Oncol. 24 (1995) 379-387
25. Norum, J.: Complete remission after repeated trofosfamide treatment in relapsing high grade malignant non-hodgkin's lymphoma - a case report. Acta Oncol. 33 (1994) 831-833
26. Panitch, M. S., B. Berg: Brainstem tumors of childhood and adolescence. Am. J. Di. Chid. 119 (1970) 465-472
27. Plate, K. H., et al.: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992 359 (6398) 845-848
28. Reagan, T. J., et al.: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg. 44 (1976) 186-190
29. Scheef, W., et al.: Trofosfamid in hoher Dosierung beim Mammakarzinom: Krankenhausarzt 57 (1484) 935-942
30. Sheline, G. E.: Radiation therapy of brain tumors. Cancer 39 (2 Suppl., 1977) 873-881
31. Wist, E., T. Risberg: Trofosfamide in non-Hodgkin's lymphoma - a phase II study. Acta Oncol. 30 (1991) 819-821
32. Wolf, A., et al.: Glioblastoma with extraneural metastasis by way of ventriculopleural anastomosis. Trans. Am. Neurol. Assoc. 79 (1954) 140-142
33. Wolff, J. E. A., et al.: Steroid inhibition of neuronal microvessel morphogenesis in vitro: receptor mediation and astroglial dependence. J. Neurochem. 58 (1992) 909-915
34. Wolff, J. E. A., et al.: Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res. 604 (1993) 79-85
35. Wolff, J. E. A., et al.: Oral treatment of childhood glioma with trofosfamide and etoposide. Journal of Neuro-Oncol. 21 (1994) 50/P197
36. Wolff, J. E. A.: Die Wirkung von Dexamethasone auf maligne Gliome: Ergebnisse experimenteller Studien. Aktuelle Onkologie 88, Zuckschwerdt Verlag München 1995
37. Wolff, J. E. A., et al. (1996): Fertigkeitenskala Münster heidelberg, ein Meßinstrument zum globalen Vergleich von Krankheitsfolgen. Klin Päd. im Druck